For those who would like to learn about the principles of malignant tumour staging, or for those who would like to brush up on their knowledge, this new series of online educational modules will help - and it's available for free on ecancer.
These modules on TNM Staging have been developed through an exciting collaboration between ecancer and the UICC (Union for International Cancer Control).
The educational course will educate the cancer community on the globally accepted classification of malignant tumours.
The modules follow the UICC guidelines for TNM staging, including an Introduction to the TNM classification system and TNM classification of Breast, Colorectal, Cervix, Prostate, Lung and Lip and Oral Cavity tumours.
UICC representatives Dr Liesbet Van Eycken, Dr James Brierley and Dr Malcolm Mason worked with ecancer to develop these educational materials.
"Learners will be able to understand the general principles of the UICC TNM Classification of Malignant Tumours and the structure of the UICC TNM Classification 7th edition," says Prof Gordon McVie, Editor of ecancer.
"They should also be able to apply the UICC TNM Classification to different cancer sites."
Each module takes approximately 30 minutes to complete and includes a voice-over and interactive assessment.
"I will do more accurate inscriptions of ypTNM and rpTNM categories," said one satisfied student after completing the module. "These skills will help me to make more accurate staging."
Register for the free online educational course here
Watch a video of our Editor, Prof Gordon McVie talking about the course here
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.